RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced its participation in two upcoming healthcare conferences in September 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced its participation in two upcoming healthcare conferences in September 2024. The company will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 at 9:15 a.m. ET in New York City, and the Wells Fargo 2024 Healthcare Conference on September 5 at 3:45 p.m. ET in Boston.
RxSight specializes in providing high-quality customized vision to patients following cataract surgery. Both conference appearances will feature fireside chats with company representatives. Interested parties can access live and archived webcasts of these events through the company's investor relations website at https://investors.rxsight.com/.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +3.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September.
- Morgan Stanley 22nd Annual Global Healthcare Conference
- Fireside Chat: Wednesday, September 4, 2024, at 9:15 a.m. ET in New York City, NY
- Wells Fargo 2024 Healthcare Conference
- Fireside Chat: Thursday, September 5, 2024, at 3:45 p.m. ET in Boston, MA
Interested parties may access live and archived webcasts of these events at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.